MANHASSET, N.Y., March 16, 2023–(BUSINESS WIRE)–Mitochondria are organelles in our cells that act like batteries, processing the food we eat into energy. Through a series of studies, researchers at The Feinstein Institutes for Medical Research have shown that mitochondria transplantation (MTx), delivering new mitochondria to critical tissues, can improve survival and neurological outcomes after cardiac arrest.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230316005460/en/
Dr. Lance Becker led the new research on mitochondria transplantation. (Credit: Feinstein Institutes)
MTx is an emerging technology with the potential to help improve function in cells damaged by ischemia – lack of blood flow and oxygen – and treat many conditions like cardiac arrest or stroke. The research, led by Lance Becker, MD, professor in the Institute of Bioelectronic Medicine, published today in BMC Medicine, studied the ability and efficacy of mitochondria transplantation in a test tube (in vivo) and